Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2012

01-04-2012 | Original Article

The Biodurability of Covering Materials for Metallic Stents in a Bile Flow Phantom

Authors: Byoung Wook Bang, Seok Jeong, Don Haeng Lee, Jung Il Lee, Se Chul Lee, Sung-Gwon Kang

Published in: Digestive Diseases and Sciences | Issue 4/2012

Login to get access

Abstract

Background

Covered biliary metal stents have been introduced for the purpose of overcoming tumor ingrowth and treatment of benign biliary stricture. The aim of this study was to evaluate the biodurability of three commercially available biliary metal stent covering materials [e-PTFE (expanded polytetrafluoroethylene), silicone, and polyurethane] in a bile flow phantom.

Materials and Methods

By operation of a peristaltic pump, human bile was circulated continuously in an experimental perfusion system containing covered metal stents. Each stent was removed, respectively, 1, 2, 4, and 6 months after bile exposure. We performed a gross inspection of the covered stents. The covering membrane was detached from the stent and observed by scanning electron microscopy (SEM). Finally, we measured tensile and tear strength of the membranes.

Results

Bile-staining of the membrane showed gradual progression after bile exposure; however, progress was the fastest in e-PTFE. SEM examination showed that the polyurethane surface was smooth, and the silicone surface was relatively smooth. However, e-PTFE had a rough and uneven surface. After bile exposure, there were no significant changes in polyurethane and silicone; however, biofilms and microcracks were observed in e-PTFE. In contrast to a gradual decrease of tensile/tear strength of polyurethane and silicone, those of e-PTFE showed a rapid reduction despite of the strongest baseline tensile and tear strength.

Conclusion

e-PTFE tended to form biofilms more frequently than polyurethane and silicone during bile exposure. e-PTFE seemed to be less durable than silicone and polyurethane, however, as clinically applicable material because of strong absolute tensile/tear strengths.
Literature
1.
go back to reference Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB. Randomised trial of endoscopic setting versus surgical bypass in malignant low bileduct obstruction. Lancet. 1994;344:1655–1660.PubMedCrossRef Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB. Randomised trial of endoscopic setting versus surgical bypass in malignant low bileduct obstruction. Lancet. 1994;344:1655–1660.PubMedCrossRef
2.
go back to reference Andersen JR, Sørensen SM, Kruse A, Rokkjaer M, Matzen P. Randomized trial of endoscopic endoprosthesis versus operative bypass in malignant obstruction jaundice. Gut. 1989;30:1132–1135.PubMedCrossRef Andersen JR, Sørensen SM, Kruse A, Rokkjaer M, Matzen P. Randomized trial of endoscopic endoprosthesis versus operative bypass in malignant obstruction jaundice. Gut. 1989;30:1132–1135.PubMedCrossRef
3.
go back to reference Brountzos EN, Ptochis N, Panagiotou I, Malaqari K, Tzavara C, Kelekis D. A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting. Cardiovasc Intervent Radiol. 2007;30:66–73.PubMedCrossRef Brountzos EN, Ptochis N, Panagiotou I, Malaqari K, Tzavara C, Kelekis D. A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting. Cardiovasc Intervent Radiol. 2007;30:66–73.PubMedCrossRef
4.
go back to reference Grandini R, Fabiano S, Pipitone V, et al. Management of biliary neoplastic obstruction with two different metallic stents implanted in one session. Cardiovasc Intervent Radiol. 2005;28:48–52.CrossRef Grandini R, Fabiano S, Pipitone V, et al. Management of biliary neoplastic obstruction with two different metallic stents implanted in one session. Cardiovasc Intervent Radiol. 2005;28:48–52.CrossRef
5.
go back to reference Rossi P, Bezzi M, Salvatori FM, Panzetti C, Rossi M, Pavia G. Clinical experience with covered Wallstents for biliary malignancies: 23-month follow-up. Cardiovasc Intervent Radiol. 1997;20:441–447.PubMedCrossRef Rossi P, Bezzi M, Salvatori FM, Panzetti C, Rossi M, Pavia G. Clinical experience with covered Wallstents for biliary malignancies: 23-month follow-up. Cardiovasc Intervent Radiol. 1997;20:441–447.PubMedCrossRef
6.
go back to reference Saito H, Sakurai Y, Takamura A, Horio K. Biliary endoprosthesis using Gore-Tex covered expandable metallic stents: preliminary clinical evaluation. Nippon Igaku Hoshasen Gakkai Zasshi. 1994;54:180–182.PubMed Saito H, Sakurai Y, Takamura A, Horio K. Biliary endoprosthesis using Gore-Tex covered expandable metallic stents: preliminary clinical evaluation. Nippon Igaku Hoshasen Gakkai Zasshi. 1994;54:180–182.PubMed
7.
go back to reference Saleem A, Leggett CL, Murad MH, Baron TH. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction. Gastrointest Endosc. 2011;74:321–327.PubMedCrossRef Saleem A, Leggett CL, Murad MH, Baron TH. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction. Gastrointest Endosc. 2011;74:321–327.PubMedCrossRef
8.
go back to reference Isayama H, Komatsu Y, Tsujino T, et al. A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction. Gut. 2004;53:729–734.PubMedCrossRef Isayama H, Komatsu Y, Tsujino T, et al. A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction. Gut. 2004;53:729–734.PubMedCrossRef
9.
go back to reference Telford JJ, Carr-Locke DL, Baron TH, et al. A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc. 2010;72:907–914.PubMedCrossRef Telford JJ, Carr-Locke DL, Baron TH, et al. A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc. 2010;72:907–914.PubMedCrossRef
10.
go back to reference Kullman E, Frozanpor F, Söderlund C, et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc. 2010;72:915–923.PubMedCrossRef Kullman E, Frozanpor F, Söderlund C, et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc. 2010;72:915–923.PubMedCrossRef
11.
go back to reference Kanasaki S, Furukawa A, Kane T, Murata K. Polyurethane-covered nitinol Strecker stents as primary palliative treatment of malignant biliary obstruction. Cardiovasc Intervent Radiol. 2000;23:114–120.PubMedCrossRef Kanasaki S, Furukawa A, Kane T, Murata K. Polyurethane-covered nitinol Strecker stents as primary palliative treatment of malignant biliary obstruction. Cardiovasc Intervent Radiol. 2000;23:114–120.PubMedCrossRef
12.
go back to reference Maccinoni F, Rossi M, Salvatori FM, Ricci P, Bezzi M, Rossi P. Metallic stents in benign biliary stricture: three-year follow-up. Cardiovasc Intervent Radiol. 1992;15:360–366.CrossRef Maccinoni F, Rossi M, Salvatori FM, Ricci P, Bezzi M, Rossi P. Metallic stents in benign biliary stricture: three-year follow-up. Cardiovasc Intervent Radiol. 1992;15:360–366.CrossRef
13.
go back to reference Yoon HK, Sung KB, Song HY, et al. Benign biliary strictures associated with recurrent pyogenic changitis: treatment with expandable metallic stents. Am J Roentgenol. 1997;169:1523–1527. Yoon HK, Sung KB, Song HY, et al. Benign biliary strictures associated with recurrent pyogenic changitis: treatment with expandable metallic stents. Am J Roentgenol. 1997;169:1523–1527.
14.
go back to reference Behm B, Brock A, Clarke BW, et al. Partially covered self-expandable metallic stents for benign biliary strictures due to chronic pancreatitis. Endoscopiy. 2009;41:547–551.CrossRef Behm B, Brock A, Clarke BW, et al. Partially covered self-expandable metallic stents for benign biliary strictures due to chronic pancreatitis. Endoscopiy. 2009;41:547–551.CrossRef
15.
go back to reference Hausegger KA, Thurnher S, Bodendorfer G, et al. Treatment of malignant biliary obstruction with polyurethane covered Wallstents. Am J Roentgenol. 1998;170:403–408. Hausegger KA, Thurnher S, Bodendorfer G, et al. Treatment of malignant biliary obstruction with polyurethane covered Wallstents. Am J Roentgenol. 1998;170:403–408.
16.
go back to reference Kim DH, Kang SG, Choi JR, Byun JN, Kim YC, Ahn YM. Evaluation of the biodurability of polyurethane-covered stent using a flow phantom. Korean J Radiol. 2001;2:75–79.PubMedCrossRef Kim DH, Kang SG, Choi JR, Byun JN, Kim YC, Ahn YM. Evaluation of the biodurability of polyurethane-covered stent using a flow phantom. Korean J Radiol. 2001;2:75–79.PubMedCrossRef
17.
go back to reference Severini A, Mantero S, Tanzi MC, et al. In vivo study of polyurethane-coated Gianturco-Rosch biliary Z-stents. Cardiovasc Intervent Radiol. 1999;22:510–514.PubMedCrossRef Severini A, Mantero S, Tanzi MC, et al. In vivo study of polyurethane-coated Gianturco-Rosch biliary Z-stents. Cardiovasc Intervent Radiol. 1999;22:510–514.PubMedCrossRef
18.
go back to reference Yasumori K, Mahmoudi N, Wright KC, Wallace S, Gianturco C. Placement of covered self-expanding metallic stents in the common bile duct: a feasibility study. J Vasc Interv Radiol. 1993;4:773–778.PubMedCrossRef Yasumori K, Mahmoudi N, Wright KC, Wallace S, Gianturco C. Placement of covered self-expanding metallic stents in the common bile duct: a feasibility study. J Vasc Interv Radiol. 1993;4:773–778.PubMedCrossRef
19.
go back to reference Baron TH. Palliation of malignant obstructive jaundice. Gastroenterol Clin North Am. 2006;35:101–112.PubMedCrossRef Baron TH. Palliation of malignant obstructive jaundice. Gastroenterol Clin North Am. 2006;35:101–112.PubMedCrossRef
20.
go back to reference Guaglianone E, Cardines R, Vuotto C, et al. Microbial biofilmes associated with biliary stent clogging. FEMS Immunol Med Microbiol. 2010;59:410–420.PubMed Guaglianone E, Cardines R, Vuotto C, et al. Microbial biofilmes associated with biliary stent clogging. FEMS Immunol Med Microbiol. 2010;59:410–420.PubMed
21.
go back to reference Hirabayashi K, Saitoh H, Ijima H, Takenawa T, Kodama M, Hori M. Influence of fibril length upon ePTFE graft healing and host modification of the implant. J Biomed Mater Res. 1992;26:1433–1447.PubMedCrossRef Hirabayashi K, Saitoh H, Ijima H, Takenawa T, Kodama M, Hori M. Influence of fibril length upon ePTFE graft healing and host modification of the implant. J Biomed Mater Res. 1992;26:1433–1447.PubMedCrossRef
22.
go back to reference Hatzidakis A, Krokidis M, Kalbakis K, Romanos J, Petrakis I, Gourtsoyiannis N. ePTFE/FEP-covered metallic stents for palliation of malignant biliary disease: can tumor ingrowth be prevented? Cardiovasc Intervent Radiol. 2007;30:950–958.PubMedCrossRef Hatzidakis A, Krokidis M, Kalbakis K, Romanos J, Petrakis I, Gourtsoyiannis N. ePTFE/FEP-covered metallic stents for palliation of malignant biliary disease: can tumor ingrowth be prevented? Cardiovasc Intervent Radiol. 2007;30:950–958.PubMedCrossRef
23.
go back to reference Gwon DI, Ko GY, Kim JH, et al. A comparative analysis of PTFE-covered and uncovered stents for palliative treatment of malignant extrahepatic biliary obstruction. Am J Roentgenol. 2010;195:463–469.CrossRef Gwon DI, Ko GY, Kim JH, et al. A comparative analysis of PTFE-covered and uncovered stents for palliative treatment of malignant extrahepatic biliary obstruction. Am J Roentgenol. 2010;195:463–469.CrossRef
24.
go back to reference Khan I, Smith N, Jones E, Finch DS, Cameron RE. Analysis and evaluation of a biomedical polycarbonate urethane tested in an in vitro study and an ovine arthroplasty model. Part I: materials selection and evaluation. Biomaterials. 2005;26:621–631.PubMedCrossRef Khan I, Smith N, Jones E, Finch DS, Cameron RE. Analysis and evaluation of a biomedical polycarbonate urethane tested in an in vitro study and an ovine arthroplasty model. Part I: materials selection and evaluation. Biomaterials. 2005;26:621–631.PubMedCrossRef
Metadata
Title
The Biodurability of Covering Materials for Metallic Stents in a Bile Flow Phantom
Authors
Byoung Wook Bang
Seok Jeong
Don Haeng Lee
Jung Il Lee
Se Chul Lee
Sung-Gwon Kang
Publication date
01-04-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1958-6

Other articles of this Issue 4/2012

Digestive Diseases and Sciences 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.